13-cis-retinoic acid plus interferon-alpha in solid tumors: keeping the cart behind the horse.
Lippman
S M
SM
Hong
W K
WK
D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015474:Isotretinoin / Q000627:therapeutic use*; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000628:therapy; D012878:Skin Neoplasms / Q000628:therapy; D014412:Tumor Virus Infections / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000628:therapy
D016898:Interferon-alpha; D015474:Isotretinoin